Editas Medicine ends development of its gene-editing therapy for thalassaemia and sickle cell, shedding 65% of staff and narrowing its R&D focus.

Latest news, opinion, and in-depth reporting from around the Internet. The Daily Dot is the hometown newspaper of the World Wide Web.